The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?
Journal of Fungi · 31.03.2023 · 9 (4) · 430
DOI: 10.3390/jof9040430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fungi, online erschienen am 31.03.2023. Verfasst von Carlos A Alvarez-Moreno und 8 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad Nacional de Colombia, Clínica Universitaria Colombia, Clínica Colsanitas, Bogotá 111321, Colombia. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candida auris has become a major health threat due to its transmissibility, multidrug resistance and severe outcomes. In a case-control design, 74 hospitalised patients with candidemia were enrolled. In total, 22 cases (29.7%) and 52 controls (C. albicans, 21.6%; C. parapsilosis, 21.6%; C. tropicalis, 21.6%; C. glabrata, 1.4%) were included and analysed in this study. Risk factors, clinical and microbiological characteristics and outcomes of patients with C. auris and non-auris Candida species (NACS) candidemia were compared. Previous fluconazole exposure was significantly higher in C. auris candidemia patients (OR 3.3; 1.15–9.5). Most C. auris isolates were resistant to fluconazole (86.3%) and amphotericin B (59%) whilst NACS isolates were generally susceptible. No isolates resistant to echinocandins were detected. The average time to start antifungal therapy was 3.6 days. Sixty-three (85.1%) patients received adequate antifungal therapy, without significant differences between the two groups. The crude mortality at 30 and 90 days of candidemia was up to 37.8% and 40.5%, respectively. However, there was no difference in mortality both at 30 and 90 days between the group with candidemia by C. auris (31.8%) and by NACS (42.3%) (OR 0.6; 95% IC 0.24–1.97) and 36.4% and 42.3% (0.77; 0.27–2.1), respectively. In this study, mortality due to candidemia between C. auris and NACS was similar. Appropriate antifungal therapy in both groups may have contributed to finding no differences in outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Medicina, Universidad Nacional de Colombia, Clínica Universitaria Colombia, Clínica Colsanitas, Bogotá 111321, Colombia.
- Grupo CINBIOS, Programa de Microbiología, Universidad Popular del Cesar, Valledupar 200004, Colombia.
- Centro de Investigaciones Microbiológicas del Cesar (CIMCE), Valledupar 200002, Colombia.
- Cibles et Médicaments des Infections et de l'Immunité, Nantes Université, CHU de Nantes, IICiMed, 10 UR1155, 44000 Nantes, France.
- Unidad de Investigacion en Proteómica y Micosis Humanas, Grupo de investigacion en Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias Pontificia Universidad Javeriana, Bogotá 110231, Colombia.
ORCID-Profile: Carlos A Alvarez-Moreno, Andrés Ceballos-Garzon, Claudia M Parra-Giraldo, Patrice Le Pape
Zitieren
APA
Alvarez-Moreno, C. A., Morales-López, S., Rodriguez, G. J., Rodriguez, J. Y., Robert, E., Picot, C., Ceballos-Garzon, A., Parra-Giraldo, C. M., & Le Pape, P. (2023). The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?. Journal of Fungi, 9(4), 430. https://doi.org/10.3390/jof9040430
Vancouver
Alvarez-Moreno CA, Morales-López S, Rodriguez GJ, Rodriguez JY, Robert E, Picot C, et al. The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?. Journal of Fungi. 2023;9(4):430. doi:10.3390/jof9040430
BibTeX
@article{AlvarezMoreno2023,
author = {Alvarez-Moreno, Carlos A and Morales-López, Soraya and Rodriguez, Gerson J and Rodriguez, Jose Y and Robert, Estelle and Picot, Carine and Ceballos-Garzon, Andrés and Parra-Giraldo, Claudia M and Le Pape, Patrice},
title = {The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?},
journal = {Journal of Fungi},
year = {2023},
volume = {9},
number = {4},
pages = {430},
doi = {10.3390/jof9040430}
}
EUVIMED